menu

Medical Industry Feature: Urothelial Carcinoma: Case Study on Disease Progression After Platinum Chemotherapy

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Urothelial Carcinoma: Case Study on Disease Progression After Platinum Chemotherapy

Urothelial Carcinoma: Case Study on Disease Progression After Platinum Chemotherapy
RestartResume
Even after a urothelial carcinoma patient receives platinum-containing chemotherapy, disease progression is still possible, as this case study shows.
  • Sponsored by

  • Overview

    Join Dr. Peter O’Donnell, associate professor of medicine in the Department of Medicine at the University of Chicago, as he discusses a hypothetical urothelial carcinoma patient case study from diagnosis to post-chemotherapy.

    US-OBD-00061 03/19

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.